The UK-wide medicines regulatory authority, the Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with other regulatory authorities in helping to resolve the ongoing manufacturing and quality problems at the Canadian site. In the UK, there is an alternative licensed product, OncoTICE, manufactured by MSD.